An increased ratio of interleukin-1 receptor antagonist to interleukin- 1α in inflammatory skin diseases

Experimental Dermatology

Volumn 7, Issue 6, 1998, Pages 327-334

  Terui, T ^a   Hirao, T ^b   Sato, Y ^b   Uesugi, T ^a   Honda, M ^a   Iguchi, M ^a   Matsumura, N ^a   Kudoh, K ^a   Aiba, S ^a   Tagami, H ^a  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Inst for Adv Skin Research Inc   (Japan)

Author keywords

Atopic dermatitis; IL 1ra; IL 1 ; Psoriasis; Stratum corneum

Indexed keywords

GLUCOCORTICOID; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1ALPHA;

ARTICLE; ATOPIC DERMATITIS; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; INFLAMMATION; INFLAMMATORY DISEASE; KERATINOCYTE; PSORIASIS; SKIN DISEASE; STEROID THERAPY; STRATUM CORNEUM; TOPICAL DRUG ADMINISTRATION;

EID: 7844242540     PISSN: 09066705     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0625.1998.tb00332.x     Document Type: Article

References (41)

1. Eisenberg S P, Evans R J, Arend W P et al. Primary structure and functional expression from complementary DNA of a human interleukin-1 receptor antagonist. Nature 1990: 343: 341-346.
2. Dinarello C A. Blocking IL-1: interleukin 1 and interleukin-1 antagonism. Blood 1991: 77: 1627-1652.
3. Haskill S, Martin G, Van Le L et al. cDNA cloning of an intracellular form of the human interleukin 1 receptor antagonist associated with epithelium. Proc Natl Acad Sci USA 1991: 88: 3681-3685.
4. Bigler C F, Norris D A, Weston W L et al. Interleukin-1 receptor antagonist production by human keratinocytes. J Invest Dermatol 1992: 98: 38-44.
5. Gruaz-Chatellard D, Baumberger C, Saurat J H. Interleukin 1 receptor antagonist in human epidermis and cultured keratinocytes. FEBS Lett 1991: 294: 137-140.
6. Terui T, Ishii K, Ozawa M et al. C3 production of cultured human epidermal keratinocytes is enhanced by IFN-γ and TNF-α through different pathways. J Invest Dermatol 1997: 108: 62-67.
7. Kupper T S, Ballard D W, Chua A O. Human keratinocytes contain mRNA indistinguishable from monocyte interleukin 1α and β mRNA. Keratinocyte epidermal cell-derived thymocyte-activating factor is identical to interleukin 1. J Exp Med 1986: 164: 2095-2100.
8. Gahring L C, Buckley A, Daynes R A. Presence of epidermal-derived thymocyte activating factor/interleukin 1 in normal human SC. J Clin Invest 1985: 76: 1585-1591.
9. Takematsu H, Suzuki R, Tagami H et al. Interleukin-1-like activity in horny layer extracts: Decreased activity in scale extracts of psoriasis and sterile pustular dermatoses. Dermatologica 1986: 172: 236-240.
10. Terui T, Suzuki R, Kumagai K et al. Absence of IL-1 inhibitor in psoriatic scale extracts. Tohoku J Exp Med 1988: 156: 149-156.
11. Kupper T S. The activated keratinocyte: A model for inducible cytokine production by non-bone marrow-derived cells in cutaneous inflammatory and immune responses. J Invest Dermatol 1990: 94: 146s-150s.
12. Dripps D J, Brandhuber B J, Thompson R C, Eisenberg S R Interleukin-1 (IL-1) receptor antagonist binds to the 80-kDa IL-1 receptor but does not initiate IL-1 signal transduction. J Biol Chem 1991: 266: 10331-10336.
13. Granowitz E V, Clark B D, Mancilla J, Dinarello C A. Interleukin-1 receptor antagonist competitively inhibits the binding of interleukin-1 to the type II interleukin-1 receptor. J Biol Chem 1991: 266: 14147-14150.
14. Romero L I, Ikejima T, Pincus S H. In situ localization of interleukin-1 in normal and psoriatic skin. J Invest Dermatol 1989: 3: 518-522.
15. Hammerberg C, Arend W P, Fisher G L et al. Interleukin-1 receptor antagonist in normal and psoriatic epidermis. J Clin Invest 1992: 90: 571-583.
16. Kristensen M, Deleuran B, Eedy D J et al. Distribution of interleukin-1 receptor antagonist protein (IRAP), interleukin 1 receptor, and interleukin-1 a in normal and psoriatic skin. Decreased expression of IRAP in psoriatic lesional epidermis. Br J Dermatol 1992: 127: 305-311.
17. Murphy G M, Dowd P M, Hudspith B N et al. Local increase in interleukin-1-like activity following UVB irradiation of human skin in vivo Photodermatology 1989: 6: 268-274.
18. Garmyn M, Yaar M, Boileau N et al. Effect of aging and habitual sun exposure on the genetic response of cultured human keratinocytes to solar-stimulated irradiation. J Invest Dermatol 1992: 99: 743-748.
19. Hirao T, Aoki H, Yoshida T et al. Elevation of interleukin 1 receptor antagonist in the SC of sun-exposed and ultraviolet B-irradiated human skin. J Invest Dermatol 1996: 106: 1102-1107.
20. Hirao T, Aoki H, Ichikawa H et al. Characterization of an interleukin 1 receptor antagonist protein released from ultraviolet-irradiated epidermal sheet. J Dermatol Sci 1997: 14: 189-198.
21. Horii I, Nakayama Y, Obata M et al. SC hydration and amino acid content in xerotic skin. Br J Dermatol 1989: 121: 587-592.
22. Bradford M M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976: 72: 248-254.
23. Cooper K D, Hammerberg C, Baadsgaard O et al. IL-1 activity is reduced in psoriatic skin: decreased IL-1α and increased nonfunctional IL-1β. J Immunol 1990: 144: 4593-4603.
24. Mizutani H, Black R, Kupper T S. Human keratinocytes produce but do not process prointerleukin-1 beta: different strategies of IL-1 production and processing in monocytes and keratinocytes. J Clin Invest 1991: 87: 1066-1071.
25. Nylander-Lundqvist E N, Egelrud T. Biologically active, alternatively processed interleukin-1β in psoriatic scales. Eur J Immunol 1997: 27: 2165-2171.
26. Debets R, Hegmans J P, Croughs P et al The IL-1 system in psoriatic skin: IL-1 antagonist sphere of influence in lesional psoriatic epidermis. J Immunol 1997: 158: 2955-2963.
27. Krzesicki R F, Hatfield C A, Bienkowski M J et al. Regulation of expression of IL-1 receptor antagonist protein in human synovial and dermal fibroblasts. J Immunol 1993: 150: 4008-4018.
28. McColl S R, Paquin R, Menard C et al. Human neutrophils produce high levels of the interleukin 1 receptor antagonist in response to granulocyte/macrophage colony stimulating factor and tumor necrosis factor α. J Exp Med 1992: 176: 593-598.
29. Arend W P, Smith M F Jr, Janson R W et al. IL-1 receptor antagonist and IL-1β production in human monocytes are regulated differently. J Immunol 1991: 147: 1530-1536.
30. Janson R W, Hance K R, Arend W P. Production of IL-1 receptor antagonist by human in vitro-derived macrophages. J Immunol 1991: 147: 4218-4223.
31. Lennard A, Gorman P, Carrier M et al. Cloning and chromosome mapping of the human interleukin-1 receptor antagonist gene. Cytokine 1992: 4: 83-89.
32. Smith M F Jr, Eidlen D, Brewer M T et al. Human IL-1 receptor antagonist promoter: cell type-specific activity and identification of regulatory regions. J Immunol 1992: 149: 2000-2007.
33. Smith M F Jr, Eidlen D, Arend W P et al. LPS-induced expression of the human IL-1 receptor antagonist gene is controlled by multiple interacting promoter elements. J Immunol 1994: 153: 3584-3593.
34. Butcher C, Steinkasserer A, Tejura S et al. Comparison of two promoters controlling expression of secreted or intracellular IL-1 receptor antagonist. J Immunol 1994: 153: 701-711.
35. Muzio M, Polentarutti N, Sironi M et al. Cloning and characterization of a new isoform of the interleukin 1 receptor antagonist. J Exp Med 1995: 182: 623-628.
36. Turner M, Chantry D, Katsikis P et al. Induction of the interleukin 1 receptor antagonist protein by transforming growth factor-β. Eur J Immunol 1991: 21: 1635-1639.
37. Orino E, Sone S, Nii A et al. IL-4 up-regulates IL-1 receptor antagonist gene expression and its production in human blood monocytes. J Immunol 1992: 149: 925-931.
38. Vannier E, Miller L C, Dinarello C A. Coordinated anti-inflammatory effects of interleukin 4: interleukin 4 suppresses interleukin 1 production but up-regulates gene expression and synthesis of interleukin 1 receptor antagonist. Proc Natl Acad Sci USA 1992: 89: 4076-4080.
39. Tilg H, Mier J W, Vogel W et al. Induction of circulating IL-1 receptor antagonist by IFN treatment. J Immunol 1993: 150: 4687-4692.
40. Ruth J H, Bienkowski M, Warmington K S et al. IL-1 receptor antagonist (IL-1ra) expression, function, and cytokine-mediated regulation during mycobacterial and schistosomal antigen-elicited granuloma formation. J Immunol 1996: 156: 2503-2509.
41. Kutsch C L, Norris D A, Arend W P. Tumor necrosis factor-α induces interleukin-Iα and interleukin-1 receptor antagonist production by cultured human keratinocytes. J Invest Dermatol 1993: 101: 79-85.